Cargando…
1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab
BACKGROUND: Non-meningococcal and nongonococcal Neisseria spp. are usually commensal and rarely cause invasive disease in humans. Eculizumab, a terminal complement inhibitor, increases susceptibility to meningococcal disease, but data on atypical Neisseria spp. disease in persons receiving eculizuma...
Autores principales: | Crew, Page, McNamara, Lucy, Waldron, Peter, McCulley, Lynda, Jones, S Christopher, Bersoff-Matcha, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252520/ http://dx.doi.org/10.1093/ofid/ofy210.1386 |
Ejemplares similares
-
Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab
por: Nolfi-Donegan, Deirdre, et al.
Publicado: (2018) -
Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States
por: Bozio, Catherine H., et al.
Publicado: (2020) -
Commensal Neisseria species share immune suppressive mechanisms with Neisseria gonorrhoeae
por: Zhu, Weiyan, et al.
Publicado: (2023) -
Antimicrobial Resistance Profiles of Human Commensal Neisseria Species
por: Goytia, Maira, et al.
Publicado: (2021) -
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
por: McNamara, Lucy A., et al.
Publicado: (2017)